Case number 1:18-cv-00350
Biogen International GmbH v. IMPAX Laboratories, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 8, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (1) |
| Jul 8, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (1) |
| Jul 8, 2020 | 1 | Complaint (12) |
| Sep 5, 2018 | N/A | Terminated Case (0) Docket Text: CASE CLOSED (See D.I. 166 in lead case no. 17-823). (ntl) |
| May 22, 2018 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:17-cv-823-LPS. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 17-823-LPS ONLY. (ntl) |
| May 22, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (16 in 1:18-cv-00337-LPS, 16 in 1:18-cv-00350-LPS) Stipulated Order Consolidating Actions, Addressing Case Schedule, and Adopting Protective Order. Signed by Judge Leonard P. Stark on 5/18/18. Associated Cases: 1:18-cv-00337-LPS, 1:18-cv-00350-LPS (ntl) |
| May 18, 2018 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Fed. R. Civ. P. 26(a)(1) Initial Disclosures of Plaintiff; (2) Biogen's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (3) Biogen's Initial Discovery In Patent Litigation Pursuant to Paragraph 4(a) of the Default Standard For Discovery filed by Biogen International GmbH.(Mayo, Andrew) |
| May 17, 2018 | 16 | Stipulation (3) Docket Text: STIPULATION Consolidating Actions, Addressing Case Schedule, and Adopting Protective Order, by Biogen International GmbH. (Balick, Steven) |
| May 4, 2018 | 15 | Answer to Counterclaim (9) Docket Text: ANSWER to [14] Answer to Complaint, Counterclaim by Biogen International GmbH.(Balick, Steven) |
| Apr 20, 2018 | 14 | Answer to Complaint (21) Docket Text: Amended ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by IMPAX Laboratories, Inc..(Phillips, John) |
| Apr 16, 2018 | 13 | Answer to Counterclaim (8) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Biogen International GmbH.(Mayo, Andrew) |
| Apr 9, 2018 | N/A | SO ORDERED (0) |
| Apr 6, 2018 | 12 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Impax Laboratories, Inc.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendant Impax Laboratories, Inc.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by IMPAX Laboratories, Inc..(Bilson, David) |
| Apr 5, 2018 | 11 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner - filed by IMPAX Laboratories, Inc.. (Attachments: # (1) Certification of Kevin E. Warner)(Bilson, David) |
| Apr 5, 2018 | 11 | Certification of Kevin E. Warner (1) |
| Apr 4, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney John R. McNair for IMPAX Laboratories, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (crb) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 3, 2018 | N/A | SO ORDERED (0) |
| Apr 3, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 2, 2018 | 10 | Certification of Jovial Wong (1) |
| Apr 2, 2018 | 10 | Certification of John R. McNair (1) |
| Apr 2, 2018 | 10 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jovial Wong and John R. McNair - filed by IMPAX Laboratories, Inc.. (Attachments: # (1) Certification of Jovial Wong, # (2) Certification of John R. McNair)(Bilson, David) |
| Mar 26, 2018 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by IMPAX Laboratories, Inc.. (Phillips, John) |
| Mar 26, 2018 | 8 | Answer to Complaint (19) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by IMPAX Laboratories, Inc..(Phillips, John) |
| Mar 15, 2018 | N/A | SO ORDERED (0) |
| Mar 14, 2018 | 7 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biogen Inc., Corporate Parent Biogen MA Inc., Corporate Parent Biogen Luxembourg Holding Sarl, Corporate Parent Biogen Switzerland Holdings GmbH for Biogen International GmbH filed by Biogen International GmbH. (Mayo, Andrew) |
| Mar 14, 2018 | 6 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Li Feng, Sanya Sukduang, Andrew E. Renison, and Jeanette M. Roorda - filed by Biogen International GmbH. (Mayo, Andrew) |
| Mar 8, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:18-cv-00337-LPS, 1:18-cv-00350-LPS (rjb) |
| Mar 6, 2018 | 5 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Biogen International GmbH. IMPAX Laboratories, Inc. served on 3/6/2018, answer due 3/27/2018. (Balick, Steven) |
| Mar 6, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to IMPAX Laboratories, Inc. on 3/6/2018. (sar) |
| Mar 6, 2018 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (nmg) |
| Mar 5, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,509,376; 7,320,999. (nmg) |
| Mar 5, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/23/2018. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/27/2020. (nmg) |
| Mar 5, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Mar 5, 2018 | 1 | Civil Cover Sheet (2) |
| Mar 5, 2018 | 1 | Exhibit B (8) |
| Mar 5, 2018 | 1 | Main Document (12) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against IMPAX Laboratories, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2335422.) - filed by Biogen International GmbH. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet)(nmg) |
| Mar 5, 2018 | 1 | Exhibit A (7) |
| Mar 5, 2018 | 1 | Complaint* (1) |
